Study Finds More Failures of Sprint Fidelis Leads in Heart Devices: Medtronic Heart Lead Recall News Article Excerpt

Medtronic Recall Blog

Read excerpts from the latest news covering the Medtronic recall and lawsuits

March 15, 2010: Update: Eighth Circuit Sets New Date for Oral Argument on Appeal of Federal Case Dismissal

February 4, 2010: Medical Study: Medtronic Sprint Fidelis heart lead fracture rate is increasing exponentially

Free Case Evaluation

Lieff Cabraser represents persons across America injured by the Medtronic Sprint Fidelis heart lead. Click here to contact an experienced injury attorney at Lieff Cabraser for a free case evaluation. Or call us toll-free at 1-800-948-2181.

Our Promise to You

Clients represented by our firm filed the first personal injury lawsuits in the nation against Medtronic.
We have been appointed to a leadership role among plaintiffs' counsel in the litigation against Medtronic in federal court.
Our injury lawyers have years of experience successfully representing clients in personal injury cases. We provide each client with high-level individualized representation.
There is no charge or obligation for our review of your injury lawsuit.
We have retained product safety and medical experts nationwide to assist our clients with their claims.
In addition to a team of experienced lawyers, we have dedicated nurses, legal assistants and case clerks to assist our attorneys in the Medtronic recall litigation. Our firm has six full-time nurses, including ones with decades of experience working with heart patients.

Medtronic Heart Lead Recall
News Article Excerpt

February 23, 2009

New York Times, "Study Finds More Failure of Heart Device"

A widely used heart device recalled two years ago by Medtronic may be failing in patients at a rate significantly higher than previously known, a new report by two prominent cardiac specialists indicated. The Medtronic device, known as the Sprint Fidelis lead, is an electrical cable that connects an implanted defibrillator to a patient's heart. The study also indicated that the component's failure rate might be increasing over time, a potentially troubling development for patient care.

The new study found that the Sprint Fidelis lead was still functioning in only 88 percent of the patients studied three years after being implanted. By contrast, data collected by Medtronic, using that three-year yardstick, indicated the lead continued to work in about 95 percent of patients. The new study, published Monday on the Web site of Heart Rhythm, a medical journal, is based on combined data from 3,000 patients from two major hospitals, the Minneapolis Heart Institute and the Mayo Clinic.

Read a copy of the full article on the New York Times website [off-site link]. You can also read a copy of the new study [pdf format].

Learn more about Medtronic Sprint Fidelis lead dangers and the legal rights of patients with these leads.

About Lieff Cabraser

Founded in 1972, Lieff Cabraser Heimann & Bernstein, LLP is an over sixty attorney law firm with offices in San Francisco, New York and Nashville. For the last seven years, the National Law Journal has recognized Lieff Cabraser as one of the top plaintiff law firms in America.

To learn more about the advantages our lawyers offer clients in personal injury and wrongful death cases, click here.

TRADEMARK NOTICE: "Medtronic" is a trademark of Medtronic, Inc. Lieff Cabraser is in no way affiliated with Medtronic, Inc. The use of this mark is solely for informational and product identification purposes.